CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells

The failure of a long-lasting curative therapeutic benefit of currently applied chemotherapies against malignant cancers is suggested to be caused by the ineffectiveness of such interventions on cancer stem cells (CSCs). CD133/AC133 is a cell surface protein previously shown to have potential to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Poonaki, Elham, Nickel, Ann-Christin, Shafiee Ardestani, Mehdi, Rademacher, Lars, Kaul, Marilyn, Apartsin, Evgeny, Meuth, Sven G., Gorji, Ali, Janiak, Christoph, Kahlert, Ulf Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141725/
https://www.ncbi.nlm.nih.gov/pubmed/35628289
http://dx.doi.org/10.3390/ijms23105479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141725/
https://www.ncbi.nlm.nih.gov/pubmed/35628289
http://dx.doi.org/10.3390/ijms23105479

Ejemplares similares